phase 1_completion
saveInsignis Therapeutics Inc — HLK-0006 (Phase I Trial Completion)
community read0 votes
Therapy area: Immunology. Indication: Anaphylaxis, Food Allergy, Peanut Allergy
Data sources
globaldata
Found something off?
Therapy area: Immunology. Indication: Anaphylaxis, Food Allergy, Peanut Allergy
comments(0)
5-min edit window · permanent after that